|
Protagonist Therapeutics inc (PTGX) |
|
|
|
| |
Protagonist Therapeutics Inc 's vs. its Competitors Results
(List of Competitors, Financial Results 12 Months from the last period ending MRQ, in Millions of $)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
REVENUE |
NET INCOME |
NET MARGIN |
CASH FLOW |
| Protagonist Therapeutics inc |
3 Q 2024 |
PTGX |
323.80 |
170.85 |
52.76 % |
-99.41 |
| Sanofi |
4 Q 2023 |
SNY |
52,016.96 |
6,088.32 |
11.7 % |
11,309.76 |
| Novartis Ag |
4 Q 2023 |
NVS |
46,660.00 |
14,854.00 |
31.83 % |
12,407.00 |
| Astrazeneca Plc |
4 Q 2023 |
AZN |
45,811.00 |
5,961.00 |
13.01 % |
6,166.00 |
| Takeda Pharmaceutical Company Limited |
1 Q 2024 |
TAK |
29,166.69 |
986.39 |
3.38 % |
5,739.41 |
| Johnson and Johnson |
3 Q 2024 |
JNJ |
87,696.00 |
14,684.00 |
16.74 % |
252.00 |
| Pfizer Inc |
3 Q 2024 |
PFE |
60,112.00 |
4,284.00 |
7.13 % |
-2,081.00 |
| Merck and Co Inc |
3 Q 2024 |
MRK |
63,175.00 |
12,163.00 |
19.25 % |
6,019.00 |
| Bristol myers Squibb Company |
3 Q 2024 |
BMY |
47,435.00 |
-7,247.00 |
-15.28 % |
325.00 |
| Eli Lilly And Company |
3 Q 2024 |
LLY |
40,863.30 |
8,369.90 |
20.48 % |
988.20 |
| Amgen Inc |
3 Q 2024 |
AMGN |
32,534.00 |
4,230.00 |
13 % |
-25,730.00 |
| Gilead Sciences Inc |
3 Q 2024 |
GILD |
28,299.00 |
114.00 |
0.4 % |
-669.00 |
| Teva Pharmaceutical Industries Limited |
3 Q 2024 |
TEVA |
16,770.00 |
-1,250.00 |
-7.45 % |
1,069.00 |
| Viatris Inc |
3 Q 2024 |
VTRS |
15,048.50 |
-883.30 |
-5.87 % |
568.30 |
| Regeneron Pharmaceuticals Inc |
3 Q 2024 |
REGN |
13,847.10 |
4,654.50 |
33.61 % |
-148.40 |
| Argenx se |
4 Q 2023 |
ARGX |
2,494.91 |
-295.05 |
-11.83 % |
0.00 |
| Organon and Co |
3 Q 2024 |
OGN |
6,409.00 |
1,301.00 |
20.3 % |
349.00 |
| Incyte Corporation |
3 Q 2024 |
INCY |
4,075.86 |
32.48 |
0.8 % |
-1,923.10 |
| Blueprint Medicines Corporation |
3 Q 2024 |
BPMC |
440.23 |
-128.05 |
-29.09 % |
34.29 |
| Immunogen inc |
3 Q 2023 |
IMGN |
287.61 |
-73.52 |
-25.56 % |
296.02 |
| Macrogenics Inc |
3 Q 2024 |
MGNX |
141.33 |
-97.62 |
-69.07 % |
89.73 |
| Zai Lab Limited |
3 Q 2024 |
ZLAB |
355.75 |
-270.85 |
-76.13 % |
-73.39 |
| Myovant Sciences Ltd |
4 Q 2023 |
MYOV |
379.11 |
-183.77 |
-48.47 % |
-211.08 |
| Day One Biopharmaceuticals Inc |
3 Q 2024 |
DAWN |
0.00 |
-27.75 |
- |
181.59 |
| Intercept Pharmaceuticals inc |
3 Q 2023 |
ICPT |
288.25 |
-61.61 |
-21.37 % |
-16.52 |
| Tg Therapeutics Inc |
3 Q 2024 |
TGTX |
386.63 |
113.98 |
29.48 % |
156.80 |
| Puma Biotechnology Inc |
3 Q 2024 |
PBYI |
227.51 |
16.77 |
7.37 % |
4.47 |
| Mannkind Corporation |
3 Q 2024 |
MNKD |
267.20 |
21.57 |
8.07 % |
-19.91 |
| Madrigal Pharmaceuticals Inc |
3 Q 2024 |
MDGL |
0.00 |
-518.67 |
- |
175.63 |
| Deciphera Pharmaceuticals Inc |
1 Q 2024 |
DCPH |
174.91 |
-190.42 |
-108.87 % |
-23.39 |
| Akebia Therapeutics Inc |
3 Q 2024 |
AKBA |
169.76 |
-46.65 |
-27.48 % |
-12.48 |
| Casi Pharmaceuticals inc |
4 Q 2023 |
CASI |
33.88 |
-26.26 |
-77.51 % |
-14.42 |
| Cytomx Therapeutics Inc |
3 Q 2024 |
CTMX |
126.62 |
13.83 |
10.92 % |
14.66 |
| Nektar Therapeutics |
3 Q 2024 |
NKTR |
93.14 |
-168.30 |
-180.7 % |
-34.81 |
| Adc Therapeutics Sa |
3 Q 2024 |
ADCT |
123.49 |
-367.17 |
-297.34 % |
-52.61 |
| Adagene Inc |
4 Q 2023 |
ADAG |
18.11 |
-18.95 |
-104.61 % |
0.00 |
| G1 Therapeutics Inc |
2 Q 2024 |
GTHX |
58.20 |
-44.77 |
-76.93 % |
-40.90 |
| Mirati Therapeutics Inc |
3 Q 2023 |
MRTX |
38.19 |
-725.88 |
-1900.65 % |
-40.13 |
| Syndax Pharmaceuticals Inc |
3 Q 2024 |
SNDX |
139.71 |
-297.06 |
-212.63 % |
38.47 |
| Xencor Inc |
3 Q 2024 |
XNCR |
85.16 |
-201.68 |
-236.81 % |
-23.70 |
| Gossamer Bio Inc |
3 Q 2024 |
GOSS |
0.00 |
-71.65 |
- |
-54.15 |
| Affimed N v |
4 Q 2023 |
AFMD |
9.27 |
-118.65 |
-1280.22 % |
164.48 |
| Aadi Bioscience Inc |
3 Q 2024 |
AADI |
25.07 |
-61.69 |
-246.06 % |
-38.27 |
| Pulmatrix Inc |
1 Q 2024 |
PULM |
11.68 |
-8.85 |
-75.73 % |
-14.61 |
| Adlai Nortye Ltd |
4 Q 2023 |
ANL |
5.00 |
-104.87 |
-2097.42 % |
0.00 |
| Aclaris Therapeutics Inc |
3 Q 2024 |
ACRS |
27.08 |
-37.00 |
-136.65 % |
8.61 |
| I mab |
4 Q 2023 |
IMAB |
3.89 |
-206.44 |
-5302.83 % |
-193.82 |
| Novan Inc |
1 Q 2023 |
NOVN |
24.92 |
-32.05 |
-128.61 % |
-22.31 |
| Shattuck Labs Inc |
3 Q 2024 |
STTK |
6.41 |
-84.27 |
-1315.31 % |
-113.06 |
| Tonix Pharmaceuticals Holding Corp |
3 Q 2024 |
TNXP |
11.29 |
-139.27 |
-1233.5 % |
21.22 |
| Aravive Inc |
3 Q 2023 |
ARAV |
7.00 |
-39.85 |
-569.65 % |
-8.09 |
| Immuron Limited |
2 Q 2023 |
IMRN |
1.48 |
-3.79 |
-255.78 % |
3.25 |
| Bolt Biotherapeutics Inc |
3 Q 2024 |
BOLT |
9.78 |
-65.09 |
-665.56 % |
0.21 |
| Oncternal Therapeutics Inc |
3 Q 2024 |
ONCT |
2.16 |
-34.58 |
-1599.95 % |
-1.85 |
| Janux Therapeutics Inc |
3 Q 2024 |
JANX |
13.05 |
-60.54 |
-463.91 % |
9.60 |
| Abvc Biopharma Inc |
3 Q 2024 |
ABVC |
0.52 |
-8.76 |
-1672.58 % |
0.43 |
| Northwest Biotherapeutics inc |
3 Q 2024 |
NWBO |
1.56 |
-75.80 |
-4868.02 % |
5.49 |
| Therapeuticsmd Inc |
2 Q 2024 |
TXMD |
0.65 |
-6.65 |
-1024.35 % |
0.91 |
| Rapt Therapeutics Inc |
3 Q 2024 |
RAPT |
3.25 |
-107.49 |
-3308.46 % |
-16.24 |
| Allarity Therapeutics Inc |
3 Q 2024 |
ALLR |
23.79 |
-19.61 |
-82.43 % |
19.49 |
| Tyme Technologies Inc. |
2 Q 2023 |
TYME |
0.00 |
-24.19 |
- |
-30.04 |
| Cns Pharmaceuticals Inc |
3 Q 2024 |
CNSP |
0.03 |
-17.06 |
-49557.46 % |
6.06 |
| Werewolf Therapeutics Inc |
3 Q 2024 |
HOWL |
9.28 |
-62.12 |
-669.16 % |
-27.24 |
| Cytodyn inc |
3 Q 2025 |
CYDY |
0.00 |
-19.04 |
- |
16.35 |
| Olema Pharmaceuticals Inc |
3 Q 2024 |
OLMA |
0.00 |
-122.68 |
- |
-81.52 |
| Erasca Inc |
3 Q 2024 |
ERAS |
0.00 |
-159.12 |
- |
-43.98 |
| Sagimet Biosciences inc |
3 Q 2024 |
SGMT |
0.00 |
-44.10 |
- |
-26.70 |
| Gt Biopharma Inc |
2 Q 2024 |
GTBP |
0.00 |
-11.35 |
- |
6.48 |
| Ideaya Biosciences Inc |
3 Q 2024 |
IDYA |
23.39 |
-178.12 |
-761.68 % |
248.62 |
| Kinnate Biopharma Inc |
3 Q 2023 |
KNTE |
0.00 |
-127.15 |
- |
-9.31 |
| Mural Oncology Plc |
3 Q 2024 |
MURA |
0.00 |
-250.41 |
- |
112.99 |
| Alx Oncology Holdings Inc |
3 Q 2024 |
ALXO |
0.00 |
-151.16 |
- |
-3.48 |
| Allakos Inc |
3 Q 2024 |
ALLK |
0.00 |
-178.75 |
- |
-60.07 |
| Spyre Therapeutics Inc |
3 Q 2024 |
SYRE |
0.00 |
-214.90 |
- |
-20.32 |
| Biomea Fusion Inc |
3 Q 2024 |
BMEA |
0.00 |
-144.01 |
- |
-111.14 |
| Cogent Biosciences Inc |
3 Q 2024 |
COGT |
7.87 |
-242.30 |
-3078.35 % |
10.24 |
| Oric Pharmaceuticals Inc |
3 Q 2024 |
ORIC |
0.00 |
-119.87 |
- |
17.99 |
| Effector Therapeutics Inc |
1 Q 2024 |
EFTR |
0.00 |
-34.63 |
- |
5.20 |
| Innovation Pharmaceuticals Inc |
3 Q 2024 |
CTIX |
0.00 |
-2.62 |
- |
-2.10 |
| Biophytis Sa |
4 Q 2023 |
BPTS |
0.00 |
-19.07 |
- |
6.55 |
| Immuneering Corporation |
3 Q 2024 |
IMRX |
0.32 |
-58.07 |
-18320.95 % |
-22.83 |
| Verastem Inc |
3 Q 2024 |
VSTM |
3.64 |
-93.45 |
-2565.3 % |
16.65 |
| Lantern Pharma Inc |
4 Q 2023 |
LTRN |
0.00 |
-17.08 |
- |
-17.86 |
| Nuvalent Inc |
3 Q 2024 |
NUVL |
4.23 |
-224.29 |
-5298.49 % |
280.81 |
| Atossa Therapeutics Inc |
3 Q 2024 |
ATOS |
0.00 |
-25.39 |
- |
-30.55 |
| Oncosec Medical Incorporated |
4 Q 2023 |
ONCS |
0.00 |
-29.39 |
- |
-21.55 |
| Rain Oncology Inc |
3 Q 2023 |
RAIN |
0.00 |
-72.26 |
- |
-39.70 |
| Genprex Inc |
3 Q 2024 |
GNPX |
0.00 |
-22.71 |
- |
-10.22 |
| Theseus Pharmaceuticals Inc |
3 Q 2023 |
THRX |
0.00 |
-56.61 |
- |
-197.75 |
| Panbela Therapeutics Inc |
3 Q 2024 |
PBLA |
0.00 |
-27.92 |
- |
-0.77 |
| Kura Oncology Inc |
3 Q 2024 |
KURA |
0.00 |
-197.55 |
- |
20.74 |
| Zentalis Pharmaceuticals Inc |
3 Q 2024 |
ZNTL |
0.00 |
-179.33 |
- |
-69.43 |
| Nucana Plc |
4 Q 2023 |
NCNA |
0.00 |
-27.63 |
- |
87.36 |
| Pliant Therapeutics Inc |
3 Q 2024 |
PLRX |
5.03 |
-202.06 |
-4019.47 % |
19.11 |
| Nextcure Inc |
3 Q 2024 |
NXTC |
0.00 |
-58.52 |
- |
8.18 |
| Essa Pharma inc |
2 Q 2024 |
EPIX |
0.60 |
-27.67 |
-4605.76 % |
47.52 |
| Repare Therapeutics Inc |
3 Q 2024 |
RPTX |
68.68 |
-84.05 |
-122.37 % |
-26.83 |
| Syros Pharmaceuticals Inc |
3 Q 2024 |
SYRS |
9.94 |
-97.82 |
-984.45 % |
-54.91 |
| Cadrenal Therapeutics Inc |
3 Q 2024 |
CVKD |
0.00 |
0.00 |
- |
-4.50 |
| Medicinova Inc |
3 Q 2024 |
MNOV |
0.00 |
-10.29 |
- |
-9.23 |
| Checkpoint Therapeutics inc |
3 Q 2024 |
CKPT |
0.10 |
-46.47 |
-45114.56 % |
2.93 |
| Iterum Therapeutics Plc |
3 Q 2024 |
ITRM |
14.32 |
-30.55 |
-213.35 % |
8.59 |
| Vaccinex Inc |
3 Q 2024 |
VCNX |
-0.78 |
-20.17 |
- |
-0.41 |
| Verrica Pharmaceuticals Inc |
3 Q 2024 |
VRCA |
9.21 |
-84.99 |
-922.81 % |
-61.35 |
| APROX. MARKET |
3 Q |
SUBTOTAL |
596,916.61 |
59,831.48 |
10.02 % |
14,779.35 |
|
|
